Fluxus develops biochip detection platforms for sensitivity diagnostics and bioanalytical applications.
Fluxus has raised $4.7M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
Fluxus's investors include Global Health Innovative Technology Fund.
Fluxus is headquartered in Sunnyvale, United States.
Fluxus develops biochip detection platforms for sensitivity diagnostics and bioanalytical applications.
Fluxus is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fluxus — Funding & Investors." VCBacked, April 23, 2025, https://www.vcbacked.co/company/fluxus. Accessed September 30, 2026.
VCBacked. (2025). Fluxus — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fluxus
{{cite web |title=Fluxus — Funding & Investors |url=https://www.vcbacked.co/company/fluxus |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated